Celecoxib Microparticles for Inhalation in COVID-19-Related Acute Respiratory Distress Syndrome

Inhalation therapy is gaining increasing attention for the delivery of drugs destined to treat respiratory disorders associated with cytokine storms, such as COVID-19. The pathogenesis of COVID-19 includes an inflammatory storm with the release of cytokines from macrophages, which may be treated wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Villa-Hermosilla, Monica-Carolina, Negro, Sofia, Barcia, Emilia, Hurtado, Carolina, Montejo, Consuelo, Alonso, Mario, Fernandez-Carballido, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320401/
https://www.ncbi.nlm.nih.gov/pubmed/35890288
http://dx.doi.org/10.3390/pharmaceutics14071392

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320401/
https://www.ncbi.nlm.nih.gov/pubmed/35890288
http://dx.doi.org/10.3390/pharmaceutics14071392

Ejemplares similares